The product of duration and amount of proteinuria (Proteinuria Index) is a possible marker for glomerular and tubulointerstitial damage in IgA nephropathy

Nephron

Volumn 90, Issue 4, 2002, Pages 432-441

  Eiro, Masaaki ^a   Katoh, Tetsuo ^a   Kuriki, Minoru ^a   Asano, Kenichiro ^a   Watanabe, Kazuo ^a   Watanabe, Tsuyoshi ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

IgA nephropathy; Proteinuria; Renal biopsy

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DISEASE COURSE; DISEASE DURATION; DISEASE MARKER; FEMALE; GLOMERULUS; HEMATURIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; KIDNEY INJURY; KIDNEY TUBULE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN URINE LEVEL; PROTEINURIA; UREA NITROGEN BLOOD LEVEL; URINARY EXCRETION;

ADULT; BIOLOGICAL MARKERS; BIOPSY; CREATININE; DISEASE PROGRESSION; FEMALE; GLOMERULONEPHRITIS, IGA; HUMANS; KIDNEY GLOMERULUS; KIDNEY TUBULES; MALE; MIDDLE AGED; PROTEINURIA; STATISTICS; TIME FACTORS;

EID: 0036229678     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000054731     Document Type: Article

References (26)

1. IgA nephropathy: Prognostic significance of proteinuria and histological alterations
2. Renal survival rate of IgA nephropathy
3. A retrospective analysis of the natural history of primary IgA nephropathy worldwide
4. Influence of clinical and histological features on actuarial renal survival in adult patients with idiopathic IgA nephropathy, membranous nephropathy and membrano-proliferative glomerulonephritis: Survey of the recent literature
5. IgA nephropathy: 30 years on
6. Typical and atypical natural history of IgA nephropathy in adult patients
7. Clinicopathologic study on prognostic markers in IgA nephropathy
8. IgA nephropathy: A syndrome of uniform morphology, diverse clinical features and uncertain prognosis
9. Natural history and risk factors for immunoglobulin A nephropathy in Japan
10. Joint Committee of Ministry of Health and Welfare of Japan and Japanese Society of Nephrology. Clinical guidelines of IgA nephropathy
11. A controlled trial of fish oil in IgA nephropathy
12. The long-term outcome of patients with IgA nephropathy treated with fish oil in a controlled trial
13. Treatment of IgA nephropathy with eicosapentanoic acid (EPA): A two-year prospective trial
14. Effects of triple therapy in IgA nephritis: A follow-up study 5 years later
15. IgA nephropathy
16. IgA nephropathy
17. Pathophysiology of progressive nephropathies
18. Management of IgA nephropathy. Evidence-based recommendations
19. Clinicopathologic correlations in a series of 143 patients with IgA glomerulonephritis
20. IgA nephropathy in Korea: A morphological and clinical study
21. Prognostic factors in mesangial IgA glomerulonephritis: An extensive study with univariate and multivariate analyses
22. Long-term prognosis of IgA nephropathy
23. Histological grading and staging of IgA nephropathy
24. Primary IgA nephropathies in children: Prognosis and treatment
25. Clinico-pathological correlations and long-term follow-up in 253 United Kingdom patients with IgA nephropathy: A report from the MRC Glomerulonephritis Registry
26. Morphologic high-risk factors in IgA nephropathy